Skip to content
Home

Telomerase: structure, function, discovery, and biomedical relevance

Telomerase is a ribonucleoprotein enzyme that extends telomeres—repeating DNA at chromosome ends—supporting genome stability, stem cell function, and implicated in ageing and cancer.

Overview

Telomerase is a specialized ribonucleoprotein enzyme that adds repeating DNA sequences to the ends of linear chromosomes, the telomeres. In most vertebrates the repeated motif added is the hexamer TTAGGG. By counteracting the progressive shortening that occurs during DNA replication, telomerase helps protect genetic material from loss and prevents chromosome ends from being recognized as DNA damage.

Image gallery

6 Images

Composition and mechanism

Telomerase consists of two essential components: a catalytic protein subunit with reverse transcriptase activity and an integral RNA molecule that serves as the template for adding telomeric repeats. The protein component, telomerase reverse transcriptase (TERT), synthesizes DNA using the telomerase RNA template (TER or TR). The enzyme binds the single-stranded 3' overhang at a chromosome end, aligns the template, and iteratively extends the sequence to rebuild telomere length.

Telomere biology and cellular roles

Telomeres are short tandem repeats and associated proteins that form a protective cap at each chromosome terminus. Because conventional DNA polymerases cannot fully replicate the ends of linear DNA, a small segment is lost with each cell division. In cells that express telomerase—such as many stem cells, germ cells, and certain activated immune cells—this loss is offset. In most somatic cells telomerase activity is low or absent, so telomeres shorten progressively, which can contribute to replicative senescence and altered tissue function.

Historical discovery and key contributors

The idea that an enzymatic mechanism must exist to compensate for terminal sequence loss was proposed in the 1970s. Telomerase itself was identified and characterized in the 1980s in the ciliate Tetrahymena. The discovery established telomerase as a fundamentally important enzyme in chromosome biology and earned its discoverers international recognition.

Biomedical significance

Telomerase is central to research into ageing, regenerative medicine, and cancer. Reactivation of telomerase is a common feature of many cancers, allowing malignant cells to divide indefinitely. Conversely, inadequate telomerase activity in some tissues can limit regenerative capacity. Therapeutic strategies under investigation aim either to inhibit telomerase in tumors or to transiently enhance its activity in degenerative conditions, though both approaches face safety and technical challenges.

Distinctive facts and current directions

Notable points include: telomerase is absent or downregulated in most differentiated somatic cells; its RNA template differs between species; and its activity is tightly regulated by multiple proteins and signaling pathways. Ongoing research explores telomerase structure at high resolution, non-canonical roles of TERT, links between telomere length and disease risk, and potential clinical applications.

Further reading and resources

Questions and answers

Q: What is telomerase?

A: Telomerase is an RNA protein enzyme that adds DNA sequence repeats to the end of DNA strands in the telomere regions.

Q: What are telomeres?

A: Telomeres are disposable buffers blocking the ends of eukaryotic chromosomes. They consist of repeated nucleotides containing noncoding DNA.

Q: What is the function of telomeres?

A: The function of telomeres is to avoid the loss of important DNA from chromosome ends by compensating for 100-200 meaningless nucleotides lost during each replication cycle.

Q: Who first predicted a compensatory mechanism for telomere shortening?

A: Soviet biologist Alexey Olovnikov first predicted a compensatory mechanism for telomere shortening in 1973.

Q: Who discovered telomerase?

A: Carol Greider and Elizabeth Blackburn discovered telomerase in 1984 in the ciliate Tetrahymena.

Q: For what were Greider, Blackburn, and Szostak awarded?

A: Greider, Blackburn, and Szostak were awarded the 2009 Nobel Prize in Physiology or Medicine for their discovery of telomerase.

Q: How does telomerase work? A: Telomerases carry their own RNA molecule which acts as a template to elongate the shortened telomeres after each replication cycle.

Related articles

Author

AlegsaOnline.com Telomerase: structure, function, discovery, and biomedical relevance

URL: https://en.alegsaonline.com/art/96881

Share

Sources